Eisler Capital (UK)’s Far Peak Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 FPAC.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-50,000
Closed -$87K 462
2021
Q3
$87K Buy
+50,000
New +$91.4K ﹤0.01% 301

Other funds holding FPAC.WS

Eisler Capital (UK)'s FPAC.WS Position: Q4 2021 in Review

Eisler Capital (UK) sold out of Far Peak Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (FPAC.WS) in Q4 2021, closing a stake of 50,000 shares — an estimated $87K sold.

Eisler Capital (UK) first reported a position in FPAC.WS in Q3 2021 and held it in 1 quarter. The position peaked at $87K in Q3 2021. 36 funds tracked by Wall St. Rank hold FPAC.WS as of Q4 2021.

  • Eisler Capital (UK) reported no remaining Far Peak Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q4 2021 after selling out during the quarter.
  • Eisler Capital (UK) sold 50,000 Far Peak Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q4 2021, an estimated $87K.
  • Eisler Capital (UK) first reported a position in Far Peak Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q3 2021 and held it in 1 quarter.
  • Eisler Capital (UK)'s Far Peak Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $87K in Q3 2021.
  • 36 funds tracked by Wall St. Rank held Far Peak Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q4 2021.

Based on Eisler Capital (UK)'s 13F filing for Q4 2021, filed 14 Feb 2022.